Non-insulin oral drug(s)-Januvia (sitagliptin) Posts on Medivizor
Navigation Menu

Non-insulin oral drug(s)-Januvia (sitagliptin) Posts on Medivizor

Canagliflozin versus sitagliptin in type 2 diabetes

Posted by on Mar 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare blood sugar control and weight loss in patients with type 2 diabetes (T2D) who were treated with canagliflozin compared to sitagliptin. The main finding was that patients treated with canagliflozin had better blood sugar control and greater weight loss than those treated with sitagliptin. Some...

Read More

Incretin-based antidiabetic drugs and heart failure

Posted by on Feb 24, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the relationship between the use of incretin-based anti-diabetic drugs and the risk of hospitalization due to heart failure. The main finding of the study was that the use of these drugs is not associated with an increased risk of hospitalization due to heart failure. Some background There...

Read More

Continuing versus stopping sitagliptin when starting insulin glargine therapy in type 2 diabetes

Posted by on Nov 17, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to compare the effects of continuing versus stopping sitagliptin (Januvia) when starting insulin glargine (Lantus) therapy in patients with type 2 diabetes. The main finding of the study was that those who continued sitagliptin after starting insulin glargine had better blood glucose control without an increase in side...

Read More

Can dipeptidyl peptidase-4 inhibitors reduce the risk of autoimmune disease?

Posted by on Jul 21, 2014 in Diabetes mellitus | 0 comments

In a nutshell The authors evaluated the risk of autoimmune disease development in patients starting a dipeptidyl peptidase inhibitor for type 2 diabetes. Some background Dipeptidyl peptidase-4 (DPP4) is a protein that plays a major role in glucose metabolism. DPP4-inhbitors such as linagliptin (Tradjenta), saxagliptin (Onglyza) and sitagliptin...

Read More